ABG Sundal Collier acted as exclusive financial advisor to Geno, Investinor and Utsillingsplassen in the sale of Cryogenetics to Bluefront Equity

On Monday, 21 October 2024, Bluefront Equity announced the acquisition of Cryogenetics AS (“Cryogenetics”), a leading company within cryopreservation and reproductive technologies for aquaculture. Investinor will continue as a shareholder, supporting the company’s future growth and development together with Bluefront Equity.
ABG Sundal Collier acted as the exclusive financial adviser to the sellers, Geno, Investinor and Utstillingsplassen.